Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
Gilead Sciences’ $405 Million Acquisition of MiroBio
Taibang Biologic Group’s $300 Million Equity Raising
Davis Polk advised Taibang Biologic Group on the transaction. Taibang Biologic Group (previously listed as China Biologic Products Holdings on the Nasdaq Global Select Market under...
Neovia Logistics’ Recapitalization
Davis Polk advised Neovia Logistics Holdings Limited and certain of its subsidiaries on the deal. Neovia Logistics Holdings Limited announced a comprehensive recapitalization that will deleverage...
Buyers Edge Platform’s Acquisition of ArrowStream
Davis Polk advised Tailwind Capital Group on the deal. Tailwind Capital Group, LLC announced its sale of ArrowStream, Inc. to Buyers Edge Platform, LLC. Financial terms...
Revlon’s Chapter 11 Filing and $575 Million Term Loan DIP Financing
Davis Polk advised an ad hoc group of lenders in the transaction. Revlon, Inc. and certain of its subsidiaries (collectively, “Revlon”) completed a $575 million term loan...
General Motors Company’s $2.25 Billion Green Bond Offering
King & Spalding advised General Motors, while Davis Polk advised the underwriters in the offering. General Motors Company (NYSE: GM) completed the offering of $2.25 billion aggregate...
Transocean’s Amendment and Extension of Revolving Credit Facility
Davis Polk advised Citibank, the administrative agent, joint lead arranger and lender, in the transaction. Transocean Inc. executed its amendment and extension of senior secured revolving credit facility...
Ygrene Energy’s Series C Funding Round
Davis Polk advised Lightyear Capital on the deal. Ygrene Energy Fund Inc. closed its Series C funding round, with participation from Lightyear Capital and Virgo Investment Group. Founded...
Legend Biotech’s $403 Million Shares Offering
Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation. Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000...
Fifth Third Bancorp’s $1 Billion Senior Notes Offering
Davis Polk advised the underwriters on the offering. Fifth Third Bancorp executed its offering of $1 billion aggregate principal amount of 4.772% fixed-rate/floating-rate senior notes due 2030....
CSX’s $2 Billion Senior Notes Offering
Davis Polk advised CSX Corporation on the offering. CSX Corporation executed its offering of $2 billion aggregate principal amount of senior notes. The offering consisted of $950 million...
IBM’s $3.25 Billion Notes Offering
Davis Polk advised the underwriters in the offering. International Business Machines Corporation executed a public offering of $1 billion aggregate principal amount of its 4.000% notes due...